Dr. Hugo E.M. Vereecke

Dr. Hugo E.M. Vereecke (°04/07/1972) became a medical doctor at the Ghent University, Belgium (1997) and consultant anesthesiologist (2002) at the University Hospital Ghent, Belgium.
After finalizing his PhD Thesis (2007) on improving anesthetic drug titration using neuro-physiological monitoring, he proceeded an academic career at the University Medical Center Groningen (UMCG) (2010-current), the Netherlands, where he became an assistant professor in anesthesia (2012-current).
He is involved in multiple study-projects related to anesthetic pharmacology, such as: the improvement of pharmacokinetic-dynamic models for anesthetic drugs; using interaction models to predict responsiveness during anesthesia; exploring the use of electroencephalographic derived information to individualize titration of anesthetic drugs.
Dr. Hugo E.M. Vereecke currently combines his academic position with a clinical consultancy at the general hospital AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium (2016-current). He is an experienced lecturer and educator in his domain of expertise. He is co-promotor of several PhD’s and masterthesis. He volunteered in several professional societies and committees: the medical ethical
committee (2014-2016), the sedation committee (2012-2016) and chair of the incident notification commission (2012-2016) at the UMCG, program director, co chair and chair of the scientific programs of several annual meetings of ISAP (San Diego (2015) , Chicago (2017), New Orleans (2022) and the virtual meetings during the COVID pandemic in 2020 and 2021. He is the former treasurer
(2017-2018), secretarial officer (2018-2019), vice-president (2019-2020), president-elect (2020- 2021), and president (2021-2022) of the International
Society of Anaesthetic Pharmacology (ISAP). He was active member of forum 1 of the European Society of Anesthesia and Intensive care (ESAIC) (2018-2023). He is a board member of EuroSIVA(2023-current). His publication list includes peer reviewed research papers, book chapters and
editorials in several national and international scientific journals.

Share the Post:

Related Posts

EUROSIVA Lisbon 2025: A Resounding Success in Advancing IV Anesthesia Education

On May 23–24, 2025, more than 100 anesthesiologists and critical care professionals from across Europe and beyond gathered in Lisbon, Portugal, for the EuroSIVA Lisbon 2025 Postgraduate Course on IV Anaesthetic Pharmacology and Perioperative Monitoring. Held at the Main Auditorium of the Edifício Egas Moniz, Faculdade de Medicina de Lisboa, this immersive two-day event offered high-level scientific discussions, practical insights, and collaborative exchange — all under the banner “Make TIVA Simple Again.” Accredited with 15 CME credits by the European

Read More

EuroSIVA 2025: A Historic Gathering of Intravenous Anaesthesia Experts in Buenos Aires

For the first time since its foundation in 1998, EuroSIVA – the European Society for Intravenous Anaesthesia – will host its full-format event outside Europe. From May 15 to 17, 2025, Buenos Aires will welcome leading anaesthesiologists, researchers, and clinicians from around the world for a three-day conference fully dedicated to Total Intravenous Anaesthesia (TIVA). A Milestone in Anaesthesia Education EuroSIVA has been a key player in education and research in intravenous anaesthesia pharmacology. This year’s event at Palais Rouge

Read More

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Scroll al inicio

This website collects cookies to deliver better user experience